University of Zimbabwe College of Health Sciences (UZCHS), Harare, Zimbabwe.
The UZ-UCSF Program was established in 1994 to lead HIV prevention and treatment studies in Zimbabwe. UZ-UCSF is led by Drs. Z. Chirenje (UCSF and UZ), J. Hakim (UZ), and T. Chipato (UZ). UZ-UCSF has 14 ongoing clinical trials, with 15 in development, and employs over 300 expert research staff at seven research sites. UZ-UCSF has an NIH-approved Central Laboratory and Pharmacy, provides central fiscal and administrative research support, and collaborates with five NIH-sponsored HIV research networks. The UZ-UCSF investigators collaborate with UCSF faculty on clinical and implementation research, including: 1) ART for prevention, 2) prevention and treatment of TB and HIV-associated cancers, 3) pediatric ART, 4) microbicides, 5) prevention of mother-to-child transmission, 6) safer conception, 7) sexual and reproductive health integration with HIV care and treatment, 8) pharmacovigilence, 9) community HIV testing, 10) HPV and associated cervical and anal cancers, and 11) HIV testing in adolescents. UZ-UCSF leadership is participating in several NIH-sponsored training programs in Zimbabwe, including the Promoting Excellence in Research and Faculty Enhanced Career Training, MEPI, and the HIV Implementation Science Research Training Program. In order to enhance UZ as a GloCal site, UZ has changed program leadership to Dr. T. Chipato (UZ), who will work collaboratively with Dr. J. Brown (UCSF) to attract applications. UZ-UCSF will continue as a GloCal site for Zimbabwean and UC trainees in clinical and implementation research focused on HIV, other infectious diseases and their sequelae.
Site contact: Dr. Tsungai Chipato